Dr. Alexandra Boer Kimball, MD, MPH

Dr. Kimball practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Dr. Kimball's NPI, 1073503603, was assigned on October 25, 2005. Dr. Kimball graduated from Yale University School of Medicine in 1994. Dr. Kimball holds Massachusetts license 222718.

Dr. Kimball's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Dr. Kimball's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Kimball to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kimball practices. Vendor and product names are available with a free account.

Dermatology is Dr. Kimball's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Kimball is licensed in Massachusetts.

CMS data shows 102 Medicare services from Dr. Kimball across 3 procedure codes in 2024, for 41 Medicare patients. Medicare paid $4,501 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 41 Medicare patients who saw Dr. Kimball in 2024. The largest group is 65 to 74, with 18 patients. 54% of them have high blood pressure, and 51% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kimball's median patient age at 49, with 69% women.

In 2024, Dr. Kimball wrote 297 Medicare Part D claims for 37 patients. 32% of them were for generic drugs. CMS names the drug for 195 of them, across 9 drugs with 11 or more claims each, at $2,635,385 in total drug cost. In 2023, CMS named 103 claims across 7 drugs.

Dr. Kimball accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kimball as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 38 papers to Dr. Kimball, published from 2010 to 2021. 2014 was the busiest year, with 5. The most frequent topics are Psoriasis, Dermatologic Agents and Dermatology. Dr. Kimball has published most often in J Am Acad Dermatol. Dr. Kimball's most frequent co-authors are Marisa Kardos Garshick, MD, Blair B. Irwin, MD and Martin M. Okun.

Dmand AI links Dr. Kimball to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Dermatitis, Atopic, Hidradenitis Suppurativa and Psoriasis. Open Payments lists research payments to Dr. Kimball that name 3 trials.

CMS Open Payments shows 589 general payments to Dr. Kimball from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 79% of the total. Almirall LLC paid the most, $270,003. It also lists 69 research payments totaling $116,221 from 2016 to 2025, naming 3 clinical trials.

Dr. Kimball graduated from Yale University School of Medicine in 1994.